twittertopbarlinks_eventstopbarlinks_requesttopbarlinks_archives
Click here for more information about Liqofluxphenometrics515R1
Visit cricatalyst.com!Readers Poll

Money

Cyanotech sales up 12% in Fiscal Year 2013

July 15, 2013
AlgaeIndustryMagazine.com

Cyanotech’s algae cultivation and production facilities in Kona

Cyanotech’s algae cultivation and production facilities in Kona

Microalgae-based, high-value nutrition and health products manufacturer, Cyanotech Corporation, has announced financial results for fiscal year 2013, ended March 31, 2013.

For fiscal 2013 compared to fiscal 2012, net sales for the Kona, Hawaii-based company were $27,581,000 compared to $24,631,000, an increase of 12%. Gross profit was $10,958,000, with gross profit margin of 40%, compared to gross profit of $9,774,000 and gross profit margin of 40%. Net income was $4,209,000 or $0.74 per diluted share, compared to net income of $3,632,000 or $0.66 per diluted share.

Commenting on the fiscal 2013 results, President and CEO Brent Bailey said, “Fiscal 2013 net sales were a record $27,581,000 (+12%) and were driven by strong growth in our consumer business:

  • Nutrex Mainland: +54%
  • Nutrex Hawaii: +26%
  • Nutrex Direct (online): +81%
  • Nutrex International: +105%

“Retail dollar growth of our Astaxanthin and Spirulina products in the natural products channel was +41% and +35%, respectively, and our market share was 40% (+13 pts.) and 45% (+5 pts.), respectively. Net sales per capita of our Nutrex products in the Hawaii market reached $1.47 in fiscal 2013. Packaged products now generate 45% (+10 pts.) of our total revenue, yet utilize only 36% (+16 pts.) and 18% (+6 pts.) of our Spirulina and Astaxanthin production, respectively.

“Operating income for the year was negatively impacted by three factors:

  1. Under absorbed overhead due to lower than expected Spirulina production in the first three quarters of the year.
  2. The investments we are making in people, infrastructure and marketing which are driving 
our topline growth
  3. Increased legal fees.”

All Cyanotech products are produced from microalgae grown at their 90-acre facility in Kona, using patented and proprietary technology. Cyanotech distributes to nutritional supplement, nutraceutical and cosmeceutical manufacturers and marketers in more than 50 countries worldwide.

More Like This…

HOME A.I.M. Archives

Copyright ©2010-2017 AlgaeIndustryMagazine.com. All rights reserved. Permission required to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

Visit our 2017 International Reader’s Poll Platinum Sponsors

bigelow mbiolp_link sfcc

From The A.I.M. Archives

— Refresh Page for More Choices
Jason Smith reports for undercurrentnews that Kentucky-based Alltech is willing to invest in overseas algae production plants closer to its feed customers if demand for i...
Cellana, Inc., a leading developer of algae-based products for sustainable nutrition and energy applications, and PIVEG, Inc., a leader in high-specification ingredients ...
Algae Health Sciences, Inc., a subsidiary of BGG, has announced that it has submitted a New Dietary Ingredient (NDI) to the US FDA for its flagship product AstaZine® Natu...
Forbes is running an interview with Bren Smith, an Ashoka Fellow and the founder of GreenWave, an organization dedicated to restoring oceans, mitigating climate change an...
In one of the most comprehensive studies to date, University of North Carolina at Chapel Hill researchers have sequenced the genes of a harmful algal bloom, unveiling nev...
The Energy Department (DOE) has announced the selection of six projects for up to $12.9 million in federal funding, entitled, “Project Definition for Pilot- and Demonstra...